Abnormal Psychology

HomeStudy GuidesAbnormal Psychology
Menu
The Nature of Psychopathology and Abnormal Psychology
The Diagnosis of Mental Disorders

References

American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders (4th ed., text rev.). Washington, DC: Author.

Spencer, J. P. (2010). The impact of fruit flavanoids on memory and cognition. British Journal of Nutrition, 104, suppl 3: S40-7.

van Holst, R.J., van den Brink, W., Veltman D.J, & Gourdriaan A.E. (2010). Brain imaging studies in pathological gambling. Current Psychiatric Reports, 12(5), 418-425.

Scammel, T.E., & Winrow, C.J. (2009). Orexin receptors : pharmacology and therapeutic opportunities. Annual Review of Pharmacology and Toxicology. 61.

Itokawa, K., Fukul, M., Ninomiya, M., Yamamoto, T., Imabayashi, E., Tamura, N., Matsuda, H., & Araki, N. (2010). Gabapentin for kleine-levin syndrome. Internal Medicine, 48(13), 1183-1185

Simeion, D., Guralnik, O., Schmeidler, J., & Knutleska, M. (2004). Fluxoetine therapy in depersonalization disorder: randomised controlled trial. The British Journal of Psychiatry: The Journal of Mental Science, 185, 31-36.

Labree, W., Nijman H., van Marie, H., & Rassin, E. (2010). Backgrounds and characteristics of arsonists. International Journal of Law and Psychiatry, 33(3), 149-153.

Berent, D., Florkowski, A., & Galecki, P. (2010). Muchausen syndrome by proxy. Psychiatry Polska,44(2), 245-254.

Arnulf I, Lin L, Gadoth N, File J, Lecendreux M, Franco P, Zeitzer J, Lo B, Faraco JH, Mignot E. (2008). Kleine-Levin syndrome: a systematic study of 108 patients. Ann Neurol 63(4):482-93

Arnulf I, Zeitzer JM, File J, Farber N, Mignot E. (2005). Kleine-Levin syndrome: a systematic review of 186 cases in the literature. Brain,128(Pt 12):2763-76

Mignot E, Lammers GJ, Ripley B, Okun M, Nevsimalova S, Overeem S, Vankova J, Black J, Harsh J, Bassetti C, Schrader H, Nishino S: The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias. Arch Neurol 2002; 59(10):1553-62

Mignot E, Lin L, Finn L, Lopes C, Pluff K, Sundstrom ML, Young T: Correlates of sleep-onset REM periods during the Multiple Sleep Latency Test in community adults. Brain 2006; 129(Pt 6):1609-23

Ohayon MM: From wakefulness to excessive sleepiness: what we know and still need to know. Sleep Med Rev 2008; 12(2):129-41

Ohayon MM, Priest RG, Caulet M, Guilleminault C: Hypnagogic and hypnopompic hallucinations: pathological phenomena? Br J Psychiatry 1996; 169(4):459-67

Aldrich MS, Chervin RD, Malow BA: Value of the multiple sleep latency test (MSLT) for the diagnosis of narcolepsy. Sleep 1997; 20(8):620-9

Bassetti C, Aldrich MS: Idiopathic hypersomnia. A series of 42 patients. Brain 1997; 120 ( Pt 8):1423-35

Bishop C, Rosenthal L, Helmus T, Roehrs T, Roth T: The frequency of multiple sleep onset REM periods among subjects with no excessive daytime sleepiness. Sleep 1996; 19(9):727-30

Carskadon MA, Dement WC, Mitler MM, Roth T, Westbrook PR, Keenan S: Guidelines for the multiple sleep latency test (MSLT): a standard measure of sleepiness. Sleep 1986; 9(4):519-24

Singh M, Drake CL, Roth T: The prevalence of multiple sleep-onset REM periods in a population-based sample. Sleep 2006; 29(7):890-5

American Academy of Medicine: ICSD-2. International Classification of Sleep Disorders, 2nd Edition: Diagnostic and Coding Manual. Westchester, Illinois, American Academy of Sleep Medicine, 2005

Markwowska, A.L. (1999). Sex dimorphisms in the rate of age-related decline in spatial memory: relevance to alterations in the estrous cycle. Journal of Neuroscience, 19(18), 8122-8133.

Salthouse, T.A. (2009). When does age-related cognitive decline begin?. Nuerobiological Aging, 30(4), 507-514.

Gualtieri, C.T., & Johnson, J.G. (2008). Age-related cognitive decline in patients with mood disorders. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 32, 962-967.

Dell'Osso, B., Altamura, A.C., Allen, A., Marazitti, D., & Hollander, E. (2006). Epidemiologic and clinical updates on impulse control disorders: a critical review. European Archives of Psychiatry and Neuroscience. 256(8), 464-475.

Kroenke, K.(2007). Efficacy of treatment for somatoform disorders: a review of randomized controlled trials. Psychosomatic Medicine, 69,881-888.

Sumathipala, A.(2007). What is the evidence for the efficacy of treatments for somatoform disorders? Psychosomatic Medicine, 69. 889-900.

Hiller, W., Rief, W., & Brahler, E. (2007). Somatization in the population: from mild body perceptions to disabling symptoms. Social Psychiatry and Psychiatric Epidemiology, 41(9), 704-712.

Zhang, Y.F., Ren, G.F., & Zhang, X.C. (2010). Acupuncture plus cupping for treating insomnia in college students. Journal of Traditional Chinese Medicine, 30 (3), 185-189.

Hallet, M & Wu, T. (2005). A functional MRI study of automatic movements in patients with parkinson's disease, Brain, 128(10), 2250-2259.

Barsky, A. (1992). Amplification,somatization, and the somatoform disorders. Psychosomatics, 33, 28-34.

Harter,M., Baumeister, H., Reuter, K., Jacobi, F., Hofler, M., Bengel, J., & Wittchen, H. (2007). Increased 12-month prevalence rates of mental disorders in patients with chronic somatic diseases. Psychotherapy and Psychosomatics, 76, 354-360.

Keuthen, N.J., O'Sullivan, R.L., Hayday, C.F., Ricciardi, J.N., Buttolph, M.L., Jenike, M.A., & Baer, L. (1995). The massachusetts general hospital hairpulling scale 2: reliability and validity. Psychotherapy and Psychosomatics, 64(3-4), 146-148.

Licenses and Attributions